Skip to content
mielomamultiplo.com · Multiple Myeloma
Emergency 112  · SNS 24 808 24 24 24
The Multiple Myeloma symbol — find out what it means

Multiple Myeloma There is hope. There is a way forward.

information · support · hope

It is always better to be an informed patient.

News, testimonies, a space to share ideas and links that help patients and carers understand the disease better and know where to find help.

Automatic translation by MielomaAI. The original text is in Portuguese. Some parts may still appear in Portuguese while they are being translated. Português
Search the whole site

You can write in Portuguese, English, Spanish or French. The search doesn't link to accents or uppercase letters, separates the words (all must appear) and also searches for the equivalent word in other languages: "transplant" finds "transplant" and "trasplante". Searches in the original titles, translated titles into Portuguese, descriptions and abstracts. MielomaAI.

In the last 3 months. From the older news, only the title and link remain in the archive. Those that have about 1 year may no longer be up to date

Resultados para «ensaios clínicos» · 26

Looking for words: ensaios + clinicos. Saltar para: Recent news (9) · My Hematologia (10) · explicações (4) · arquivo (3)

Latest news from the last 3 months · 9

Click on an article to open it on the side with the summary. MielomaAI And the link to the source.

Summaries from My Hematologia · 10
Explanations on the website 4
Clinical trials
Studies comparing a new treatment with the best existing treatment may provide access to medications before approval. Participation is voluntary.
Smouldering myeloma
Protein M of 3 g/dL or more, or 10% to 60% plasma cells in the bone marrow, but without CRAB signs. How to manage or treat: Close monitoring (every 3 or 6 months) with imaging tests. In high-risk latency, daratumumab may be administered or entry into a clinical trial may be considered. Risk: Approximately 10% per year during the first 5 years. High risk when 2 or 3 of the following are present: more than 20% plasma cells, protein M above 2 g/dL, light chain ratio above 20. See the film "Types of myeloma" →
Extramedullary Disease
Multiple myeloma with tumors in organs or soft tissues (skin, liver, lymph nodes, nervous system), in diagnosis or, more frequently, in relapses. How it is managed or treated: Intensive treatment; CAR-T and bispecifics are options in relapse; clinical trials. Risk: High risk. See the film "Types of myeloma" →
Multiple myeloma
5% or more of plasma cells circulating in the blood. Primary (at the very beginning) or secondary (in a relapse). How to manage it: Intensive and rapid treatment; transplant for those who can; clinical trials. Risk: Very high risk: the most aggressive form. See the film "Types of myeloma" →
In the file (over 3 months, just titles) · 3

Patients and associations

Research